InflaRx NV (IFRX)
1.24
+0.06
(+5.08%)
USD |
NASDAQ |
Nov 12, 16:00
1.24
0.00 (0.00%)
After-Hours: 20:00
InflaRx Price : 1.24 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 1.21 | 1.25 | 1.15 | 1.24 | 883021.0 |
| Nov 11, 2026 | 1.30 | 1.30 | 1.17 | 1.18 | 577514.0 |
| Nov 10, 2026 | 1.30 | 1.40 | 1.21 | 1.21 | 283776.0 |
| Nov 09, 2026 | 1.30 | 1.34 | 1.211 | 1.31 | 450560.0 |
| Nov 06, 2026 | 1.22 | 1.32 | 1.17 | 1.305 | 1.083M |
| Nov 05, 2026 | 1.46 | 1.51 | 1.35 | 1.355 | 1.616M |
| Nov 04, 2026 | 1.64 | 1.719 | 1.33 | 1.48 | 1.898M |
| Nov 03, 2026 | 1.67 | 1.715 | 1.485 | 1.62 | 5.678M |
| Nov 02, 2026 | 1.68 | 1.79 | 1.63 | 1.765 | 799791.0 |
| Oct 30, 2026 | 1.71 | 1.72 | 1.621 | 1.66 | 691455.0 |
| Oct 29, 2026 | 1.74 | 1.79 | 1.71 | 1.715 | 306538.0 |
| Oct 28, 2026 | 1.67 | 1.74 | 1.65 | 1.73 | 493937.0 |
| Oct 27, 2026 | 1.59 | 1.66 | 1.57 | 1.66 | 513063.0 |
| Oct 26, 2026 | 1.56 | 1.615 | 1.54 | 1.575 | 397590.0 |
| Oct 23, 2026 | 1.51 | 1.585 | 1.48 | 1.56 | 889583.0 |
| Oct 22, 2026 | 1.55 | 1.60 | 1.51 | 1.53 | 404205.0 |
| Oct 21, 2026 | 1.55 | 1.61 | 1.54 | 1.55 | 701424.0 |
| Oct 20, 2026 | 1.45 | 1.61 | 1.44 | 1.54 | 724082.0 |
| Oct 19, 2026 | 1.33 | 1.48 | 1.285 | 1.45 | 2.806M |
| Oct 16, 2026 | 1.47 | 1.475 | 1.29 | 1.32 | 1.535M |
| Oct 15, 2026 | 1.47 | 1.53 | 1.43 | 1.44 | 552043.0 |
| Oct 14, 2026 | 1.53 | 1.536 | 1.46 | 1.48 | 585673.0 |
| Oct 13, 2026 | 1.59 | 1.605 | 1.54 | 1.55 | 367525.0 |
| Oct 12, 2026 | 1.60 | 1.64 | 1.545 | 1.59 | 467927.0 |
| Oct 09, 2026 | 1.55 | 1.695 | 1.546 | 1.60 | 740709.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| MediGene AG | 0.10 |
| BioNTech SE | 85.04 |
| Immatics NV | 6.52 |
| Arrowhead Pharmaceuticals, Inc. | 47.15 |
| Oncolytics Biotech, Inc. | 0.372 |
Price Related Metrics
| PS Ratio | 4516.99 |
| Price to Book Value | 1.116 |
| Earnings Yield | -34.38% |
| Market Cap | 182.74M |